The ANZCHOG ASM 2026 program will include plenary sessions, invited speaker sessions, industry involvement and concurrent paper sessions.
Please find below a preliminary copy of the 2026 ASM program as a guide of what to expect. Please note the program is subject to changes.
ANZCHOG 2026 ASM Program
- Main program
- Partner session
- Workshop
- Social function
- Breaks
| Time | Concert Hall (Main Room) | Cummings Room | Waratah Room | Offsite |
|---|---|---|---|---|
|
0800-0900 |
Arrival tea & coffee / registration open |
|||
|
0900-1500 |
Pre-conference Nurse Workshop
|
Pre-conference Allied Health Workshop
|
Pre-conference Pharmacy Workshop
|
Pre-conference Fellows Workshop
|
|
Sponsored by Cure Brain Cancer Foundation  |
Sponsored by My Room  |
|
||
|
1500-1600 |
Afternoon Tea Trade display and Poster viewing |
|||
|
1600-1630 |
Opening Ceremony |
|
||
|
1630-1715 |
Plenary 1 Chairs Dr Frank Alvaro and A/Prof Andy Moore |
|||
|
Precision Supportive Care in Pediatric Oncology
Dr Lillian Sung, The Hospital for Sick Children |
||||
|
1715-1800 |
Plenary 2 Chairs Dr Frank Alvaro and A/Prof Andy Moore |
|||
|
The Long and Winding Road: From leukaemia to DIPG and the pursuit of better outcomes for children with cancer
Prof Matt Dun, Hunter Medical Research Institute |
||||
|
1800-1915 |
Welcome Reception in Exhibition |
|||
|
1930-2100 |
|
Chairs Toby Trahair |
|
|
|
1930-2015
Real word experience with Dinutuximab- beta in combination with chemotherapy in the relapse or refractory high risk neuroblastoma patient Prof Holger Lode, Paediatrics at University Medicine Greifswald |
||||
|
Sponsored by Recordati Rare Diseases  |
||||
| Time | Concert Hall (Main Room) | Mulubinba Room | Cummings Room | Hunter Room (Level 3) |
|---|---|---|---|---|
|
0730-0830 |
|
|
Partner Breakfast Symposium |
|
|
|
||||
|
0800-0900 |
Arrival tea & coffee / registration open |
|||
|
0900-0945 |
Plenary 3 Chairs Kristy McCarthy and Marty Campbell |
|
|
|
|
Strategies to manage relapsed/refractory high risk neuroblastoma Prof Holger Lode, Paediatrics at University Medicine Greifswald |
||||
|
0945-1030 |
Plenary 4 Chairs Kristy McCarthy and Marty Campbell |
|||
|
Prevention of Cisplatin-induced Hearing Loss: The Time is Now
Prof David Freyer, Children’s Hospital Los Angeles |
||||
|
1030-1100 |
Morning tea Trade display and Poster viewing |
|||
|
1100-1215 |
Concurrent 1 – Oncofertility
|
Concurrent 2 – Allied Health |
Concurrent 3 – Cancer Genetics
|
|
|
Chairs: Dr Paola Kabalan-Baeza and Lyndal Moore
|
Chairs:
Rachael Fear and Louise Bourke |
Chairs:
Dr Noemi Fuentes Bolanos and Leanne Super |
||
|
1100-1130
Pause for preservation: fertility care alongside medical treatments Dr Angela Dunford, John Hunter Hospital |
1100-1130
Revolutionizing Recovery: The Power of Digital-Health and Community to Scale Exercise for Childhood Cancer Survivors Dr David Mizrahi, Daffodil Centre, University of Sydney |
1100 -1115
Patterns of Care in Paediatric Genetic Cancer Risk Clinics: A Seven-Year Review Andrew Grant, Sydney Children’s Hospital |
||
|
1115-1130
Understanding How to Best Support Families’ Undergoing Regular Cancer Surveillance, Including Whole-Body MRI, for their Child with a Genetic Cancer Risk Jacqueline Hunter, The University of Melbourne/University of New South Wales |
||||
|
1130-1145
The Impact of Unilateral Salpingo-Oophorectomy (USO) on Reproductive Health in Female Childhood Cancer Survivors: A Systematic review Dr Zobaida Edib, The University of Melbourne |
1130-1145
Embedding theory and practice for paediatric oncology social workers in a tertiary setting: A structured reflective group model Allison Rifkin, Children’s Hospital at Westmead |
1130-1145
Hope and Uncertainty: Understanding Parents’ Distress During Their Child’s Participation in a Precision Medicine Trial for Poor Prognosis Cancer Dr Kate Hetherington, UNSW/SCH |
||
|
1145-1200
Building the national investment case for CAYA oncofertility: Defining the economic architecture required to implement fertility preservation guidelines in Australian oncology systems Dr Apoorva Bhargava, The University of Melbourne |
1145-1200
Music Matters: An Innovative and National Music Therapy Service Supporting Paediatric Brain Cancer Recipients and their Families. Annette Baron, Robert Connor Dawes Foundation |
1145-1200
No survivor left behind: Integrating genetics into oncology survivorship care Tora Sibbald, The Children’s Hospital at Westmead |
||
|
1200-1215
Ovarian follicle density in under 20-year oncofertility patients Dr Michael Assis, The University of Melbourne |
1200-1215
Redesigning High-Dose Methotrexate Pathways in Paediatric Acute Lymphoblastic Leukaemia: Safer Care through Multi-Disciplinary Collaboration Dr Lauren Madigan, Sydney Children’s Hospital |
1200-1215
Beyond Surveillance: The Specialist Nurse Role in Identifying Psychological Distress in Paediatric Genetic Cancer Risk Andrew Grant, Sydney Children’s Hospital |
||
|
1215-1300 |
Focused Session 1 – Infections in Oncology
|
Focused Session 2 – Haematology
|
Focused Session 3 – Wellbeing
|
|
|
Chairs:
Richard Mitchell and Madeleine Powys |
Chairs:
Bryony Ross and Lochie Teague |
Chairs:
Margaret Allwood and Chris Williams |
||
|
1215-1237
Antibiotic decision-making in febrile neutropenia Dr Coen Butters, John Hunter Children’s Hospital 1237-1300 Prevention of Bacterial and Fungal Infections – From Guideline to Practice Dr Lillian Sung, The Hospital for Sick Children |
1215-1237 Thrombosis and Pediatric Malignancy Dr Sally Campbell, Queensland Children’s Hospital 1237-1300 Safe Paediatric Transfusion: Are we there yet? Dr Anastazia Keegan, King Edward Memorial Hospital |
1215-1237 Implementation of Group Supervision for Oncology Nurses: Caring for the Carers Dr Ben Britton, University of Newcastle 1237-1300 Implementation of Group Supervision for Oncology Nurses: Caring for the Carers Dr Stephen Spencer, Rest In Essence |
||
|
1300-1415 |
Lunch Trade display and Poster viewing |
|||
|
1415-1545 |
ANZCHOG Clinical Trials Update
Chairs
Maria Kirby
|
|
||
|
1545-1615 |
Afternoon tea Trade display and Poster viewing |
|||
|
1615-1730 |
Concurrent 4 – Leukaemias |
Concurrent 5 – Supportive Care |
Concurrent 6 – Neuro-Oncology |
|
|
Chairs:
Dr Siobhan Cross and Draga Barbaric |
Chairs:
Emma Zietsch and Naomi Holt |
Chairs:
Ti-Anna Tipper and Neev Manoharan |
||
|
1615-1630
Gut Microbiome Modulation Restores Tyrosine Kinase Inhibitor Efficacy in High-Risk Acute Lymphoblastic Leukaemia Pre-Clinical Models Dr Elyse Page, SAHMRI |
1615-1645
Work on a knife edge- negotiating specialist palliative care for an AYA population Dr Abigail Franklin, Northern Sydney Local Health District |
1615-1630
Leveraging the Immunomodulatory Effects of Dordaviprone to Induce Adaptive Immune Infiltration in Diffuse Midline Glioma Dr Mika Persson, University of Newcastle |
||
|
1630-1645
Kids Oncology And Leukaemia or Allograft – PharmacoKinetics (KOALA-PK): A Study Protocol Roxanne Dyas, Murdoch Children’s Research Institute |
1630-1645
Clinical and Molecular characteristics of Paediatric Clival Chordomas: A Single Institution Retrospective Study Dr Sumanth Nagabushan, Cancer Centre for Children Children’s Hospital at Westmead |
|||
|
1645-1700
Ultrasensitive personalised panel sequencing (UPPseq) for blood minimal residual disease monitoring in leukaemia Dr Sarah Trinder, Perth Children’s Hospital; Children’s Cancer Institute at Minderoo Children’s Comprehensive Cancer Centre |
1645-1700
Early insights, better outcomes: Refining paediatric palliative care referral through a timely decision-making guideline. Annette Vickery, Palliative Care Australia Nikki Ritchie, Sunshine Coast University Hospital |
1645-1700
Paediatric Central Nervous System Tumours in First Nations Children: Global Inequities in Incidence and Survival Eden Slicer, Telethon Kids Institute |
||
|
1700-1715
Contemporary Treatment Costs of Childhood Acute Lymphoblastic Leukaemia in Australia Dr Karen McCleary, Sydney Children’s Hospital |
1700-1715
Otoprotection At What Cost? Acute Adverse Effects of Sodium Thiosulfate in Cisplatin-Treated Patients Dr Andrea Zhu, The Royal Children’s Hospital |
1700-1715
Enhancing immunotherapeutic response in high risk medulloblastoma through integration of ATR inhibition, craniospinal irradiation, and CD47 blockade Joshua Ninan, The Kids Institute Australia |
||
|
1715-1730
Antifungal Prophylaxis Patterns and Invasive Fungal Infections Outcomes in Paediatric Allogenic HCT: A Multicentre Cohort Study Hyatt Assafiri, The Royal Children’s Hospital |
1715-1730
SPARK: Paediatric Audiovisual Distraction Device Aimee Welch, Radiation Oncology Mater Hospital Raymond Terrace |
1715-1730
High-throughput 3D modelling of medulloblastoma identifies a repurposed CNS drug targeting MYC-driven disease Dr Iman Azimi, Monash University |
||
|
1900-0000 |
Gala Dinner at Earp Distilling Co.
|
|||
|
We are delighted to award the ANZCHOG Life Member Award during the Gala Dinner Return transfers will be made available to and from Newcastle City Hall to Earp Distilling Co. ANZCHOG 2026 ASM Gala Dinner is sponsored by RUN DIPG  |
||||
| Time | Concert Hall (Main Room) | Mulubinba Room | Cummings Room |
|---|---|---|---|
|
0800-0900 |
Arrival tea & coffee / registration open |
||
|
0900-1000 |
ANZCHOG ASM Best Abstracts Chairs Dr Frank Alvaro and Prof Nicholas Gottardo |
|
|
|
0900 – 0915
Leveraging Integrated Proteogenomics to Address Molecular Heterogeneity in the Treatment of Diffuse Midline Glioma Izac Findlay, University of Newcastle |
|||
|
0900 – 0915
Leveraging Integrated Proteogenomics to Address Molecular Heterogeneity in the Treatment of Diffuse Midline Glioma Izac Findlay, University of Newcastle |
|||
|
0915 – 0930
Ultrasensitive whole-genome-based, tumour-informed circulating tumour DNA detection correlates with treatment response and outcome in paediatric solid tumour A/Prof Loretta Lau, Children’s Cancer Institute |
|||
|
0930-0945
Efficacy and Tolerability of Trametinib in the Treatment of Plexiform Neurofibroma in Children, Adolescents and Young Adults – Results of the TiNT Study, a phase 2 trial Dr Andrew Dodgshun, Christchurch Hospital |
|||
|
0945-1000
Decoding Childhood Cancer: Interplay of Germline Risk and Somatic Drivers Dr Noemi Fuentes Bolanos, Kids Cancer Centre. Sydney Children’s Hospital |
|||
|
1000-1115 |
Concurrent 7 – Solid Tumours |
Concurrent 8 – Survivorship |
Concurrent 9 – Psychosocial |
|
Chairs:
Dr Marty Campbel and Marion Matteos |
Chairs:
A/Prof Thomas Walwyn and Karen Johnston |
Chairs:
Maria McCarthy and Kate Oliver |
|
|
1000-1015
Delphi consensus recommendations for second opinion seeking in paediatric oncology Dr Hilary Cahill, Royal Manchester Children’s Hospital |
1000-1015
Long-Term Obesity Risk in Childhood Cancer Survivors in Singapore: A Retrospective Audit Dr Yuan Rui Leon Tan, Kk Women’s And Children’s Hospital |
1000-1015
“We are broken”: Highlighting the need to integrate financial support into paediatric cancer care Dr Axelle Marjolin, Redkite |
|
|
1015-1030
Mapping the Proton Beam Therapy Referral Pathway: A quality assurance evaluation at a tertiary paediatric oncology centre Dr Eun Ji Hwang, Westmead Hospital |
1015-1030
Provision of Information and Resources After Childhood Cancer Treatment: ‘What Happens Now?’ Christine Cashion, QCH and QUT |
1015-1030
A holistic approach to psychosocial support for parents and families of paediatric cancer patients in Aotearoa New Zealand: The National Child Cancer Counselling Network. Prof Kirsty Ross, Massey University |
|
|
1030-1045
Identifying molecular mechanisms of cisplatin resistance in osteosarcoma using functional genomic screening and multiomic profiling of in vitro models. Dr Elise Young, Hudson Institute of Medical Research |
1030-1045
Enhancing radiotherapy with DNA damage response inhibitors in medulloblastoma: Balancing cure and neurodevelopmental outcomes Dr Annabel Short, The Kids Research Institute Australia |
1030-1045
Digital Support for Parents of Children and Adolescents with Cancer: Lessons from the Compass Program Pilot Rhiannon Edge, Redkite |
|
|
1045-1100
Outcomes of multisystem Langerhans cell histiocytosis in Australian children: a single-centre retrospective study Dr Clare Parker, Royal Children’s Hospital, Melbourne |
1045-1100
Self-reported cognitive and educational impacts among survivors of child, adolescent and young adult cancer A/Prof Joanna Fardell, University of New South Wales |
1045-1100
Integrating SSPedi Patient-Reported Outcomes into Early-Phase Paediatric Precision Oncology Trials: Feasibility Insights from PROptimise Dr Denise Connolly, Sydney Children’s Hospital |
|
|
1100-1115
The Australian Pharmacogenetic Paediatric Oncology Network for Drug Safety – a national genomic infrastructure for AI driven discovery Dr Julian Stolper, Murdoch Children’s Research Institute |
1100-1115
Patient and family voices on childhood cancer survivorship: Identifying unmet needs across the survivorship continuum Dr Udani Reets, Children’s Cancer CoLab |
1100-1115
Combined Q&A |
|
|
1115-1200 |
Morning tea Trade display and Poster viewing |
||
|
|
Partner Morning Symposium Chairs Dr Janis Chamberlain |
Partner Morning Symposium Chairs Dr Martin Campbell |
|
|
1130-1200
Updates on BFM and COG Dr Draga Barbaric, Kids Cancer Centre, Sydney Children’s Hospital Dr Sarah Trinder, Perth Children’s Hospital, Children’s Cancer Institute at Minderoo Children’s Comprehensive Cancer Centre Sponsored by Jazz Pharmaceuticals  |
1120-1200
Hearing Beyond Survival: Preventing Cisplatin-Induced Ototoxicity – From Evidence to Practice Prof David Freyer, Children’s Hospital Los Angeles Prof Catherine Birman, The University of Sydney Sponsored by Norgine 
|
||
|
1200-1222 |
Plenary 5 Chairs Bhavna Padhye and Janis Chamberlain |
|
|
|
Vascular malformations aren’t tumours so why do they need oncologists?
Dr David Lord, John Hunter Children’s Hospital |
|||
|
1222-1245 |
Plenary 6 Chairs Bhavna Padhye and Janis Chamberlain |
||
|
Paediatric Surgical oncology as a core pillar of paediatric oncology care
Prof Jonathan Karpelowsky, Children’s Hospital at Westmead/ University of Sydney |
|||
|
1245-1308 |
Plenary 7 Chairs Kristy McCarthy and Carol Doherty |
||
|
The Genomic Blueprint of ALL: Masterpiece…or a Work in Progress? Prof Deborah White, South Australian Health and Medical Research Institute |
|||
|
1308-1330 |
Plenary 8 Chairs Kristy McCarthy and Carol Doherty |
||
|
Whole genome transcriptome sequencing in inherited bone marrow failure syndromes: The IBMDx study
Dr Lucy Fox, Peter MacCallum Cancer Centre |
|||
|
1330-1400 |
Closing Ceremony |
||
|
Join us at the Closing Ceremony as we celebrate excellence in research through the presentation of the Abstract Awards and recognition of the ANZCHOG Jazz Pharmaceutical Travel Grant Award recipients. These awards and grants acknowledge outstanding submissions, support emerging researchers and clinicians, and recognise significant contributions to the scientific program.
|
|||
